--- title: Recent Posts (17) description: (17) --- - [Our Customers and Partners](http://www.congenica.com/our-customers) - [Our Product Portfolio](http://www.congenica.com/congenica-products) - **Inherited Diseases** - [Rare Disease](http://www.congenica.com/congenica-rare-disease) - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer) - [Prenatal Health](http://www.congenica.com/congenica-prenatal) - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening) - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro) - **Somatic Oncology** - [Solid Tumours](http://www.congenica.com/congenica-oncology) - **Pathogen** - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance) - [Our Services](http://www.congenica.com/congenica-services) - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services) - [Professional Services](http://www.congenica.com/professional-services) - [Customer Support](http://www.congenica.com/customer-support) - [Pharma Services](http://www.congenica.com/pharma-services) - Resources - [Publications](http://www.congenica.com/publications) - [Supporting materials](http://www.congenica.com/resources) - [News](https://blog.congenica.com/) - [Events and webinars](http://www.congenica.com/events-webinars) - [About us](http://www.congenica.com) - [Leadership Team](http://www.congenica.com/leadership) - [Quality](http://www.congenica.com/quality) - [Investors](http://www.congenica.com/investors) - [People and Vacancies](http://www.congenica.com/people) - [Contact us](http://www.congenica.com/contact) Login ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) # Latest News and Blogs ![Neurodevelopmental disorders - discovering the underlying cause and how genomic data analysis ended a 21-year diagnostic odyssey](https://blog.congenica.com/hs-fs/hubfs/VAC14%20Paper.jpg?width=320&height=192&name=VAC14%20Paper.jpg) 9/10/2019 #### [Neurodevelopmental disorders - discovering the underlying cause and how genomic data analysis ended a 21-year diagnostic odyssey](https://blog.congenica.com/2019/09/10/discovering-the-underlying-cause-of-neurodevelopmental-disorders) Thousands of babies are born each year with a neurodevelopmental disorder and the global estimate for individuals with intellectual disability is 10.37/1,000 (1) and 62/10,000 (2) for autism. ![Congenica a finalist in multiple industry awards](https://blog.congenica.com/hs-fs/hubfs/Medtech_Insight.jpg?width=320&height=192&name=Medtech_Insight.jpg) 8/8/2019 #### [Congenica a finalist in multiple industry awards](https://blog.congenica.com/2019/08/08/congenica-a-finalist-in-multiple-industry-awards) Congenica a finalist in multiple industry awards ![Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally](https://blog.congenica.com/hs-fs/hubfs/Sequence-Data_2-800x533.jpg?width=320&height=192&name=Sequence-Data_2-800x533.jpg) 7/22/2019 #### [Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally](https://blog.congenica.com/2019/07/22/congenica-simplifies-software-branding-while-adding-cnv-calling-capability) Congenica today announced it has renamed its software platform Congenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing. ![Enabling genomic medicine](https://blog.congenica.com/hs-fs/hubfs/Congenica%20Logo%20Off%20Centre-2.jpg?width=320&height=192&name=Congenica%20Logo%20Off%20Centre-2.jpg) 7/16/2019 #### [Enabling genomic medicine](https://blog.congenica.com/2019/07/16/enabling-genomic-medicine-the-congenica-brand-identity) Our brand identity reflects the unique work we do and our commitment to empowering healthcare professionals to make important clinical decisions. ![Should you get your genome sequenced?](https://blog.congenica.com/hs-fs/hubfs/GATC-Sequence_2.jpg?width=320&height=192&name=GATC-Sequence_2.jpg) 7/10/2019 #### [Should you get your genome sequenced?](https://blog.congenica.com/2019/07/10/would-you-get-your-genome-sequenced) If you could afford it, would you get your genome sequenced? We live in exciting times, it will not be long before we are all comparing our genome data. ![Congenica named in UK life sciences – Catalysing investment and growth report](https://blog.congenica.com/hs-fs/hubfs/Global-increase_2.jpg?width=320&height=192&name=Global-increase_2.jpg) 6/18/2019 #### [Congenica named in UK life sciences – Catalysing investment and growth report](https://blog.congenica.com/2019/06/18/congenica-named-in-uk-life-sciences-catalysing-investment-and-growth-report) Congenica named in UK life sciences – Catalysing investment and growth report ![Improving Diagnosis for Patients with Rare Genetic Disease](https://blog.congenica.com/hs-fs/hubfs/Satellite%20Event.jpg?width=320&height=192&name=Satellite%20Event.jpg) 6/15/2019 #### [Improving Diagnosis for Patients with Rare Genetic Disease](https://blog.congenica.com/2019/06/15/sub-event-eshg-satellite-event) Improving Diagnosis for Patients with Rare Genetic Disease ![BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform](https://blog.congenica.com/hs-fs/hubfs/Loading-Sequencer_2.jpg?width=320&height=192&name=Loading-Sequencer_2.jpg) 6/14/2019 #### [BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform](https://blog.congenica.com/2019/06/14/bgi-genomics-launch-clinical-research-whole-exome-sequencing-and-interpretation-service-using-congenica-clinical-decision-support-platform) BGI Genomics Launch Clinical Research Whole Exome Sequencing and Interpretation Service Using Congenica Clinical Decision Support Platform ![Congenica supports fast, meaningful results achieved in important project](https://blog.congenica.com/hs-fs/hubfs/29156746_l_2.jpg?width=320&height=192&name=29156746_l_2.jpg) 6/11/2019 #### [Congenica supports fast, meaningful results achieved in important project](https://blog.congenica.com/2019/06/11/congenica-supports-fast-meaningful-results-achieved-in-important-project) Congenica supports fast, meaningful results achieved in important project ![Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round](https://blog.congenica.com/hs-fs/hubfs/Money_2-1-800x533.jpg?width=320&height=192&name=Money_2-1-800x533.jpg) 4/30/2019 #### [Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round](https://blog.congenica.com/2019/04/30/congenica-raises-additional-13m-for-series-b-funding-round) Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round ![Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society](https://blog.congenica.com/hs-fs/hubfs/Matt%20Hurles-1.jpg?width=320&height=192&name=Matt%20Hurles-1.jpg) 4/18/2019 #### [Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society](https://blog.congenica.com/2019/04/18/scientific-director-matthew-hurles-elected-to-fellowship-of-the-royal-society) Congenica co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society ![Congenica Announces On-Premise Deployment Option for its Genomic Analysis Platform](https://blog.congenica.com/hs-fs/hubfs/Servers_2.jpg?width=320&height=192&name=Servers_2.jpg) 4/1/2019 #### [Congenica Announces On-Premise Deployment Option for its Genomic Analysis Platform](https://blog.congenica.com/2019/04/01/congenica-announces-on-premise-deployment-option-for-sapientia-platform) Congenica Announces On-Premise Deployment Option for its Sapientia Platform ##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory. - [Privacy Policy](http://www.congenica.com/privacy-policy) - [Cookie Policy](http://www.congenica.com/cookie-policy) Log in to Congenica ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) ![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png) Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.